TrialThe Lancet. Neurology2022

Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.

Giulia Coarelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.